A randomised clinical trial to evaluate the efficacy and safety of a new pediculicide made with saponified olive oil in the eradication of head lice.

A new study has compared the efficacy and safety of a new pediculicide, Inex Pediculicide Soap® with Paranix® via a randomised clinical trial involving children diagnosed with pediculosis and 6 paediatricians from the community of Madrid, Spain.

The study by Soler et.al published in the March 2017 SEMERGEN Journal revealed that the efficacy of Inex Pediculicide Soap® and Paranix®, 14 days after treatment, was 76.2% in the group treated with Inex Pediculicide Soap® and 79.2% in the Paranix® group with no adverse effects observed during the treatment.

In this randomised clinical trial, treatment was administered to a total of 45 children (aged between 5 and 15 years) on days 1 and 7 and results evaluated in 4 visits, that is, day 2, 7, 9 and 14.

The findings revealed that the 2 products are effective and safe in the eradication therapy Pediculus humanus capitis with no statistical differences.